Yahoo Web Search

  1. Most Useful Ranking List of Heart health. Our top lists help you make informed choices quickly

Search results

  1. Sep 24, 2024 · We are also building up evidence that inflammation and the immune system play an important role in the development of atrial fibrillation, and this could open up new treatments for atrial fibrillation and heart scarring too.

  2. May 21, 2024 · Radiofrequency-based ablation (RF ablation) is the most common form of ablation used to treat atrial fibrillation. The process works by using a catheter to deliver bursts of radiofrequency...

    • Gigen Mammoser
  3. Mar 6, 2023 · The study is the first prospective, global clinical trial for the use of pulsed field ablation, which issues electrical pulses, for treating the heart rhythm disorder atrial fibrillation (AFib). Ablation is a minimally invasive catheter-based procedure that disables portions of heart tissue that cause irregular heart rhythms.

  4. Jun 17, 2024 · Heart device makers including J&J believe they have a solution to narrow that gap, a procedure called pulsed field ablation (PFA). The technology has sparked tremendous buzz among heart specialists and Wall Street analysts, who predict speedy adoption of the new technique.

  5. Nov 8, 2023 · New late-breaking science from AHA 2023 sheds light on new treatments for patients with atrial fibrillation (AFib). In ARTESIA, the results of which were also published in the New England Journal of Medicine, patients with subclinical AFib who were treated with apixaban (5 mg/twice daily) were 37% less likely to have a stroke or systemic ...

  6. Jul 30, 2024 · Instead of applying heat or cold energy as in traditional ablation, the PFA catheter therapy uses short bursts of high energy called irreversible electroporation to affect heart tissue that causes atrial fibrillation.

  7. People also ask

  8. In a 2003 paper in the American Journal of Cardiology, he showed that a new emergency department pathway for atrial fibrillation could reduce the hospitalization rate for the condition from 75 to 30 percent.